Enfermedad de Dupuytren

EMC - Aparato Locomotor - Tập 45 - Trang 1-14 - 2012
J. Beaudreuil1, H. Lellouche1, E. Roulot1, P. Orcel1, T. Bardin1
1Unité Rhumatologique des Affections de la Main (URAM), Service de Rhumatologie, Hôpital Lariboisière, 2, rue Ambroise-Paré, 75010 Paris, France

Tài liệu tham khảo

Dupuytren, 1831, De la rétraction des doigts par suite d’une affection de l’aponévrose palmaire. Description de la maladie. Opération chirurgicale qui convient dans ce cas, J Univ Hebd Chir Prat, 5, 352 Thurston, 2003, Dupuytren's disease, J Bone Joint Surg Br, 85, 469, 10.1302/0301-620X.85B4.14215 Whaley, 1993, Dupuytren's disease: a legacy of the north?, J Hand Surg [Br], 18, 363, 10.1016/0266-7681(93)90065-N Elliot, 1988, The early history of contracture of the palmar fascia. Part 1: the origin of the disease: the curse of the MacCrimmons: the hand of benediction: Cline's contracture, J Hand Surg [Br], 13, 246, 10.1016/0266-7681(88)90078-2 Dupuytren, 1834, Permanent retraction of fingers produced by an affection of the palmar fascia, Lancet, 2, 222 Early, 1962, Population studies in Dupuytren's contracture, J Bone Joint Surg Br, 44, 602, 10.1302/0301-620X.44B3.602 Flatt, 2001, The vikings and Baron Dupuytren's disease, Proc, 14, 378 Gudmundsson, 2001 Finsen, 2002, The prevalence of Dupuytren's disease among 2 different ethnic groups in northern Norway, J Hand Surg [Am], 27, 115, 10.1053/jhsu.2002.29486 Saboeiro, 2000, Racial distribution of Dupuytren's disease in department of veterans affairs patients, Plast Reconstr Surg, 106, 71, 10.1097/00006534-200007000-00013 McFarlane, 1990, Epidemiology of surgical patients, Vol5 Hindocha, 2009, Epidemiological evaluation of Dupuytren's disease incidence and prevalence rates in relation to etiology, Hand, 4, 256, 10.1007/s11552-008-9160-9 Godtfredsen, 2004, A prospective study linked both alcohol and tobacco to Dupuytren's disease, J Clin Epidemiol, 57, 858, 10.1016/j.jclinepi.2003.11.015 KhanAA, 2004, The role of manual occupation in the etiology of Dupuytren's disease in men in England and Wales, J Hand Surg [Br], 29, 12, 10.1016/j.jhsb.2003.08.012 Geoghegan, 2004, Dupuytren's disease risk factors, J Hand Surg [Br], 29, 423, 10.1016/j.jhsb.2004.06.006 Gudmundsson, 2000, Epidemiology of Dupuytren's disease. Clinical, serological, and social assessment. The Reykjavik study, J Clin Epidemiol, 53, 291, 10.1016/S0895-4356(99)00145-6 Lucas, 2008, Dupuytren's disease: personal factors and occupational exposure, Am J Ind Med, 51, 9, 10.1002/ajim.20542 Zerajic, 2004, Dupuytren's disease in Bosnia and Herzegovina. An epidemiological study, BMC Musculoskelt Disord, 5, 10, 10.1186/1471-2474-5-10 Gudmundsson, 2001, Dupuytren's disease, alcohol consumtion and alcoholism, Scand J Prim Health Care, 19, 186, 10.1080/028134301316982441 Hindocha, 2006, The heritability of Dupuytren's disease: familial aggregation and its clinical significance, J Hand Surg [Am], 31, 204, 10.1016/j.jhsa.2005.09.018 Ling, 1963, The genetic factor in Dupuytren's disease, J Bone Joint Surg Br, 45, 709, 10.1302/0301-620X.45B4.709 Logan, 2005, Can rock climbing lead to Dupuytren's disease?, Br J Sports Med, 39, 639, 10.1136/bjsm.2004.015792 Critchley, 1976, Dupuytren's disease in epilepsy: result of prolonged administration of anticonvulsants, J Neurol Neurosurg Psychiatry, 39, 498, 10.1136/jnnp.39.5.498 Florence, 2002, Rheumatological complications associated with the use of indinavir and other protease inhibitors, Ann Rheum Dis, 61, 82, 10.1136/ard.61.1.82 Hines, 1955, Peripheral neuritis following isoniazid therapy; appearance of Dupuytren's contracture and Raynaud's phenomenon, JAMA, 159, 1197, 10.1001/jama.1955.02960290023006c Roulot, 2003, À la découverte de l’aponévrose palmaire Luck, 1959, Dupuytren's contracture: a new concept of pathogenesis correlated with surgical management, J Bone Joint Surg Am, 41, 635, 10.2106/00004623-195941040-00008 Verjee, 2009, Myofibroblast distribution in Dupuytren's cords: correlation with digital contracture, J Hand Surg [Am], 34, 1785, 10.1016/j.jhsa.2009.08.005 Vi, 2010, The potential roles of cell migration and extra-cellular matrix interactions in Dupuytren's disease progression and recurrence, Med Hypotheses, 74, 510, 10.1016/j.mehy.2009.10.009 Cordova, 2005, Dupuytren's contracture: an update of biomolecular aspects and therapeutic perspectives, J Hand Surg [Br], 30, 557, 10.1016/j.jhsb.2005.07.002 McFarlane, 1986, Anatomie de la maladie de Dupuytren Bayat, 2005, Identification of a novel mitochondrial mutation in Dupuytren's disease using multiplex DHPLC, Plast Reconstr Surg, 115, 134, 10.1097/01.PRS.0000146039.21330.CE Townley, 2006, Dupuytren's contracture unfolded, BMJ, 332, 397, 10.1136/bmj.332.7538.397 Wooldridge, 1988, Four related fibrosing diseases, Postgrad Med, 84, 269, 10.1080/00325481.1988.11700386 Hu, 2005, Ry al. Mapping of an autosomal dominant gene for Dupuytren's contracture to chromosome 16q in a Swedish family, Clin Genet, 68, 424, 10.1111/j.1399-0004.2005.00504.x Bayat, 2002, Genetic susceptibility in Dupuytren's disease: lack of association of a novel transforming growth factor beta (2) polymorphism in Dupuytren's disease, J Hand Surg [Br], 27, 47, 10.1054/jhsb.2001.0689 Bayat, 2002, Genetic susceptibility in Dupuytren's disease. TGF-b1 polymorphisms and Dupuytren's disease, J Bone Joint Surg Br, 84, 211, 10.1302/0301-620X.84B2.12083 Bayat, 2003, Genetic susceptibility in Dupuytren's disease: transforming growth factor beta receptor (TGFbR) gene polymorphisms and Dupuytren's disease, Br J Plast Surg, 56, 328, 10.1016/S0007-1226(03)00176-0 Bayat, 2003, Genetic susceptibility in Dupuytren's disease: association of Zf9 transcription factor gene, Plast Reconstr Surg, 111, 2133, 10.1097/01.PRS.0000060531.98180.32 Badalamente, 1996, The role of transforming growth factor beta in Dupuytren's disease, J Hand Surg [Am], 21, 210, 10.1016/S0363-5023(96)80102-X Bisson, 2009, Transforming factor-beta 1 stimulation enhances Dupuytren's fibroblast contraction in response to uniaxial mechanical load within a 3-dimensional collagen gel, J Hand Surg [Am], 34, 1102, 10.1016/j.jhsa.2009.02.008 Bisson, 2003, The different characteristics of Dupuytren's disease fibroblasts derived from either nodule or cord: expression of a-smooth muscle actin and the response to stimulation by TGF-b1, J Hand Surg [Br], 28, 351, 10.1016/S0266-7681(03)00135-9 Augoff, 2005, Epidermal growth factor in Dupuytren's disease, Plast Reconstr Surg, 115, 128, 10.1097/01.PRS.0000146038.61595.4A Augoff, 2005, Epidermal growth factor receptor (EGF-R) in Dupuytren's disease, J Hand Surg [Br], 30, 570, 10.1016/j.jhsb.2005.06.008 Magro, 1997, Myofibroblasts of palmar fibromatosis co-express transforming growth factor-alpha and epidermal growth factor receptor, J Pathol, 181, 213, 10.1002/(SICI)1096-9896(199702)181:2<213::AID-PATH739>3.0.CO;2-4 Lee, 2006, Expression of a novel gene. MafB, in Dupuytren's disease, J Hand Surg [Am], 31, 211, 10.1016/j.jhsa.2005.09.007 Johnston, 2007, A complete expression profile of matrix-degrading metalloproteinases in Dupuytren's disease, J Hand Surg [Am], 32, 343, 10.1016/j.jhsa.2006.12.010 Ulrich, 2003, Matrix metalloproteinases and tissue inhibitors of metalloproteinases in sera and tissue of patients with Dupuytren's disease, Plast Reconstr Surg, 112, 1279, 10.1097/01.PRS.0000081462.40448.49 Lermusiaux, 2003, Les fausses maladies de Dupuytren Tubiana, 1961, Classification de la maladie de Dupuytren, Mem Acad Chir (Paris), 87, 886 Tubiana, 1986, Évaluation des déformations dans la maladie de Dupuytren, Ann Chir Main, 5, 5, 10.1016/S0753-9053(86)80043-6 Lermusiaux, 2001, Le traitement des maladies associées à la maladie de Dupuytren Beaudreuil, 2008, Traitement médical des formes graves de la maladie de Dupuytren Beaudreuil, 2009, Pronostic anatomofonctionnel de la maladie de Dupuytren : étude de 188 patients, Rev Rhum, 76, 1020 Lermusiaux, 1980, Le traitement médical de la maladie de Dupuytren Ritchie, 2004, Proximal interphalangeal joint release in Dupuytren's disease of the little finger, J Hand Surg [Br], 29, 15, 10.1016/j.jhsb.2003.08.005 Van Giffen, 2006, Dupuytren's disease: outcome of the proximal interphalangeal joint in isolated fifth ray involvement, Acta Orthop Belg, 72, 671 Tubiana, 1955, Prognosis and treatment of Dupuytren's contracture, J Bone Joint Surg Am, 37, 1155, 10.2106/00004623-195537060-00003 Chaise, 2003, Les déformations digitales en « boutonnière » Loos, 2007, 50 years experience with Dupuytren's contracture in the Erlangen University Hospital – A retrospective analysis of 2919 operated hands from 1956 to 2006, BMC Musculoskelet Disord, 8, 60, 10.1186/1471-2474-8-60 Lermusiaux, 1996, Le traitement de la maladie de Dupuytren 17 ans après Dias, 2006, Dupuytren's contracture: an audit of the outcome surgery, J Hand Surg [Br], 31, 514, 10.1016/j.jhsb.2006.05.005 Gudmundsson, 2000, Eighteen years follow-up study of the clinical manifestations and progression of Dupuytren's disease, Scand J Rheumatol, 29, 1 Hindocha, 2006, Dupuytren's diathesis revisited: evaluation of prognostic indicators for risk of disease recurrence, J Hand Surg [Am], 31, 1626, 10.1016/j.jhsa.2006.09.006 Abe, 2004, An objective method to evaluate the risk of recurrence and extension of Dupuytren's disease, J Hand Surg [Br], 29, 427, 10.1016/j.jhsb.2004.06.004 Allard, 2007, L’échelle URAM ou la première échelle d’incapacité pour maladie de Dupuytren, Rev Rhum, 74, 1017, 10.1016/j.rhum.2007.10.546 National Institute for Clinical Excellence. IPG043 Needle fasciotomy for Dupuytren's contracture - guidance. February 2004.Available from: http://guidance.nice.org.uk/IPG43/Guidance/pdf/English. Accessed 26 May 2010. Badois, 1993, Traitement non chirurgical de la maladie de Dupuytren par aponévrotomie à l’aiguille, Rev Rhum, 60, 692 Cheng, 2008, Needle aponeurotomy for Dupuytren's contracture, J Orthop Surg (Hong Kong), 16, 88, 10.1177/230949900801600120 Foucher, 2003, Percutaneous needle aponeurotomy: complications and results, J Hand Surg [Br], 28, 427, 10.1016/S0266-7681(03)00013-5 LeeMV, 2009, Needle fasciotomy for Dupuytren's disease: an Australian perspective, ANZ J Surg, 79, 776, 10.1111/j.1445-2197.2009.05101.x Van Rijssen, 2006, Acomparison of the direct outcomes of percutaneous needle fasciotomy and limited fasciotomy for Dupuytren's disease: a 6-week follow-up study, J Hand Surg [Am], 31, 717, 10.1016/j.jhsa.2006.02.021 Van Rijssen, 2006, Percutaneous needle fasciotomy in Dupuytren's disease, J Hand Surg [Br], 31, 498, 10.1016/j.jhsb.2006.03.174 Beaudreuil, 2007, Multi-aponévrotomie à l’aiguille pour maladie de Dupuytren : résultats à 18 mois d’une étude prospective, Rev Rhum, 74, 1016, 10.1016/j.rhum.2007.10.544 Bassot, 1965, Traitement de la maladie de Dupuytren par exérèse isolée ou complète par un temps plastique uniquement cutané, Lille Chir, 20, 38 Hueston, 1971, Enzymic fasciotomy, Hand, 3, 38, 10.1016/0072-968X(71)90010-6 McCarty, 1992, The long-term results of enzymic fasciotomy, J Hand Surg [Br], 17, 356, 10.1016/0266-7681(92)90129-P Badalamente, 2000, Enzyme injection as a nonoperative treatment for Dupuytren's disease, J Hand Surg [Am], 25, 629, 10.1053/jhsu.2000.6918 Badalamente, 2002, Collagen as a clinical target: nonoperative treatment of Dupuytren's disease, J Hand Surg [Am], 27, 788, 10.1053/jhsu.2002.35299 Badalamente, 2007, Efficacy and safety of injectable mixed collagenase subtypes in the treatment of Dupuytren's contracture, J Hand Surg [Am], 32, 767, 10.1016/j.jhsa.2007.04.002 Hurst, 2009, Injectable collagenase clostridium histolyticum for Dupuytren's contracture, N Engl J Med, 361, 968, 10.1056/NEJMoa0810866 Dominguez-Malagon, 1992, Clinical and cellular effects of colchicines in fibromatosis, Cancer, 69, 2478, 10.1002/1097-0142(19920515)69:10<2478::AID-CNCR2820691016>3.0.CO;2-V Kadioglu, 2000, Treatment of Peyronie disease with oral colchicines: long-term results and predictive parameters of successful outcome, Int J Impot Res, 12, 169, 10.1038/sj.ijir.3900519 Namazi, 2006, Imiquimod: a potential weapon against Dupuytren contracture, Med Hypotheses, 66, 991, 10.1016/j.mehy.2005.09.052 Swartz WM, Lalonde DH. MOC-PS(SM) CME article: Dupuytren's disease. Plast Reconstr Surg 2008;121:1-0. Bruner, 1951, Incision for plastic and reconstructive (non septic) surgery of the hand, Br J Plast Surg, 4, 48, 10.1016/S0007-1226(51)80006-7 McCash, 1964, The open palm technique in Dupuytren's contracture, Br J Plast Surg, 17, 271, 10.1016/S0007-1226(64)80043-6 Michon, 1986, Difficultés et complications dans la chirurgie de la maladie de Dupuytren Hueston, 1985, L’appareil extenseur dans la maladie de Dupuytren, Ann Chir Main, 4, 7, 10.1016/S0753-9053(85)80075-2 Messina, 1991, The TEC (continuous extension technique) for severe Dupuytren's contracture of the fingers, Ann Hand Surg, 10, 247 Benson, 1998, Dupuytren's contracture, J Am Acad Orthop Surg, 6, 24, 10.5435/00124635-199801000-00003 Macnicol, 1984, The open palm technique for Dupuytren's contracture, Int Orthop, 8, 55, 10.1007/BF00267741 Olmeda, 1986, The treatment of Dupuytren's contracture by radical aponeurectomy, Ital J Orthop Traumatol, 12, 305 Denkler, 2010, Surgical complications associated with fasciectomy for Dupuytren's disease: a 20-year review of the English literature, Eplasty, 10, e15 McFarlane, 1990, Complications and their management, Vol5 Zemel, 1991, Dupuytren's contracture in women, Hand Clin, 4, 701